Australia’s medical cannabis prescriptions jumped from 231 in 2017 to over one million by early 2024 — but high costs, rural gaps, and fragmented regulation mean the story is far from over. A 2026 narrative review maps what worked, what didn’t, and what international models can teach Australian policymakers.